Moderators Drs. Murugesh Kandasamy and Mayur Ladumor are joined by webinar presenters Drs. Aernout van Haarst and Sabina Paglialunga as they continue answering questions from their ASCPT Journal Family webinar “Alternatives for Rifampin as a CYP3A Inducer in DDI Studies in View of N-Nitrosamine Impurity Issues.” The webinar is available open access on the ASCPT website, so if you haven’t had a chance to watch it, you can do so. You can also read Drs. van Haarst’s and Paglialunga’s paper, which published in Clinical Pharmacology & Therapeutics, here.
Tagged: CPT
Call for Papers: Artificial Intelligence and Machine Learning
Clinical Pharmacology & Therapeutics (CPT) has launched a Call for Papers for its January 2024 themed issue titled “The Application of Artificial Intelligence and Machine Learning (AI/ML) in Clinical Pharmacology and Therapeutics.” Join host Alaina Webster as she welcomes CPT’s Editor-in-Chief Dr. Piet van der Graaf, Associate Editor Dr. Amita Joshi, and Guest Editor Dr. Qi Liu to discuss types of submissions they’d most like to see as well as why submitting to a themed issue could be a great visibility booster for your paper!
Translating Clinical Pharmacology for ALL
Clinical Pharmacology & Therapeutics recently published its second themed issue of 2023 – Diversity, Equity, & Inclusion: Translating Clinical Pharmacology for ALL. Join Editor-in-Chief Dr. Piet van der Graaf, Deputy Editor-in-Chief Dr. Kathy Giacomini, Associate Editor Dr. Karthik Venkatakrishnan, and Editor-in-Training Dr. Karen Brown as they discuss where diversity, equity, and inclusion (DEI) currently stands within clinical pharmacology, ideas and tools for moving it forward, and what they hope DEI will mean for future research, patients, and researchers.
If you’re interested in submitting your research for any upcoming themed issues in ASCPT’s Journal Family, you can find Calls for Papers and more information here.
Building on Biosimilars
Clinical Pharmacology & Therapeutics recently published its first themed issue of 2023 – Innovations in Biosimilars. Join Editor-in-Chief Dr. Piet van der Graaf and Guest Editor Yow-Ming Wang as they discuss what papers stood out to them, their thoughts around the growing importance of biosimilars in Clinical Pharmacology, and how the editorial team developed that interesting and somewhat playful cover.
If you’re interested in submitting your research for any upcoming themed issues in ASCPT’s Journal Family, you can find Calls for Papers and more information here.
Sharing Data to Improve Patient-Focused Outcomes
Critical Path Institute’s Dr. Diane Stephenson joins host Alaina Webster to discuss the importance of data sharing to improve patient care, particularly in Neuroscience. Diane and her co-authors recently published a Review, “Can Innovative Trial Designs in Orphan Diseases Drive Advancement of Treatments for Common Neurological Diseases?”, in the April Neuroscience-themed issue of Clinical Pharmacology & Therapeutics, and she ties this work into successful data sharing models and their impact on patient outcomes. Critical Path Institute has accumulated more than 300 clinical data studies across 15+ disease areas, and its repository of data currently includes information on the following neuroscience diseases: Alzheimer’s disease, Huntington’s disease, ataxias, Duchenne muscular dystrophy, Parkinson’s disease, and multiple sclerosis.